Randomized Trial of Fulvestrant With or Without Dasatinib in Men and Postmenopausal Women Who Have Hormone Receptor-positive Advanced Breast Cancer Previously Treated With an Aromatase Inhibitor
Public ClinicalTrials.gov record NCT00754325. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase II Randomized Trial of Fulvestrant With or Without Dasatinib in Men and Postmenopausal Women Who Have Hormone Receptor-positive Advanced Breast Cancer Previously Treated With an Aromatase Inhibitor
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to find out what effect the combination of fulvestrant (Faslodex) and dasatinib (Sprycel) has on advanced breast cancer compared to fulvestrant alone.
Study identification
- NCT ID
- NCT00754325
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 100 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2008 (Type not available)
- Primary completion
- Nov 2011 (Actual)
- Completion
- Jan 2014 (Actual)
- Last update posted
- May 26, 2016
2008 – 2014
United States locations
- U.S. sites
- 28
- U.S. states
- 11
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Northern Arizona Hematology & Oncology Associates | Sedona | Arizona | 86336-4937 | — |
| Arizona Oncol Assoc Dba (Hem Onc Physicians&Extenders) Hope | Tucson | Arizona | 85704 | — |
| Florida Cancer Institute - New Hope | Hudson | Florida | 34667-6594 | — |
| Cancer Centers Of Florida, P.A | Ocoee | Florida | 34761 | — |
| Central Indiana Cancer Centers | Carmel | Indiana | 46032 | — |
| Kansas City Cancer Center, Llc. | Overland Park | Kansas | 66210 | — |
| Minnesota Oncology Hematology, P.A. | Minneapolis | Minnesota | 55404 | — |
| Missouri Cancer Associates | Columbia | Missouri | 65201 | — |
| New York Oncology Hematology, Pc | Troy | New York | 12180 | — |
| Raleigh Hematology Oncology Associates | Raleigh | North Carolina | 27607 | — |
| Willamette Valley Cancer Center | Eugene | Oregon | 97401 | — |
| Northwest Cancer Specialists, P.C. | Portland | Oregon | 97213 | — |
| Texas Oncology-Central Austin Cancer Center | Austin | Texas | 78731 | — |
| Texas Oncology, P.A. | Bedford | Texas | 76022 | — |
| Texas Oncology, P.A. | Dallas | Texas | 75230-2510 | — |
| Texas Oncology | Dallas | Texas | 75231 | — |
| Texas Oncology Sammons Cancer Center | Dallas | Texas | 75246 | — |
| Texas Cancer Center | Denton | Texas | 76210 | — |
| El Paso Cancer Treatment Ctr - West | El Paso | Texas | 79902 | — |
| Us Oncology Research, Inc. | Houston | Texas | 77060 | — |
| Quest Diagnostic Clinical Laboratories Inc | Houston | Texas | 77072 | — |
| Cancer Care Centers Of South Texas | San Antonio | Texas | 78217 | — |
| Tyler Cancer Center | Tyler | Texas | 75702 | — |
| Texas Oncology Cancer Care And Research Center | Waco | Texas | 76712 | — |
| Texas Oncology, P.A. | Webster | Texas | 77598-4420 | — |
| Virginia Oncology Associates | Norfolk | Virginia | 23502 | — |
| Oncology & Hematology Associates Of Southwest Virginia, Inc. | Salem | Virginia | 24153 | — |
| Virginia Center Specialists, Pc | Woodbridge | Virginia | 22191 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00754325, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 26, 2016 · Synced Oct 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00754325 live on ClinicalTrials.gov.